24 Nov 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
|
20101025 Health Services |
- |
17 Nov 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
|
20101025 Health Services |
- |
28 Oct 2025
17:45 CET |
ONWARD MEDICAL |
ONWARD Medical Publishes Closing of Bookbuild Offering
|
20101025 Health Services |
- |
24 Oct 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
|
20101025 Health Services |
- |
22 Oct 2025
17:49 CEST |
ONWARD MEDICAL |
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
|
20101025 Health Services |
- |
13 Oct 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
|
20101025 Health Services |
- |
08 Oct 2025
07:30 CEST |
ONWARD MEDICAL |
Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR
|
20101025 Health Services |
- |
08 Oct 2025
07:30 CEST |
ONWARD MEDICAL |
Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
|
20101025 Health Services |
- |
18 Sep 2025
07:30 CEST |
ONWARD MEDICAL |
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
|
20101025 Health Services |
- |
08 Sep 2025
08:44 CEST |
ONWARD MEDICAL |
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
|
20101025 Health Services |
- |
02 Sep 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025
|
20101025 Health Services |
- |
18 Aug 2025
18:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
|
20101025 Health Services |
- |
06 Aug 2025
19:37 CEST |
ONWARD MEDICAL |
ONWARD Medical gibt Ernennung von Lucas Buchanan als Vorstandsmitglied bekannt
|
20101025 Health Services |
- |
06 Aug 2025
19:37 CEST |
ONWARD MEDICAL |
ONWARD Medical annonce la nomination de Lucas Buchanan à son conseil d’administration
|
20101025 Health Services |
- |
06 Aug 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
|
20101025 Health Services |
- |
07 Jul 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors
|
20101025 Health Services |
- |
01 Jul 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application
|
20101025 Health Services |
- |
17 Jun 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
|
20101025 Health Services |
- |
11 Jun 2025
19:00 CEST |
ONWARD MEDICAL |
ONWARD Medical Announces Results of its Annual General Meeting of Shareholders
|
20101025 Health Services |
- |
11 Jun 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights
|
20101025 Health Services |
- |
21 May 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants
|
20101025 Health Services |
- |
30 Apr 2025
17:35 CEST |
ONWARD MEDICAL |
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
|
20101025 Health Services |
- |
28 Apr 2025
08:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Announces Release of 2024 Annual Report
|
20101025 Health Services |
- |
24 Apr 2025
07:30 CEST |
ONWARD MEDICAL |
ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market
|
20101025 Health Services |
- |
01 Apr 2025
07:53 CEST |
ONWARD MEDICAL |
ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025
|
20101025 Health Services |
- |
01 Apr 2025
07:53 CEST |
ONWARD MEDICAL |
ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights
|
20101025 Health Services |
- |
26 Mar 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility
|
20101025 Health Services |
- |
19 Mar 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast
|
20101025 Health Services |
- |
04 Mar 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense
|
20101025 Health Services |
- |
25 Feb 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy
|
20101025 Health Services |
- |
29 Jan 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms
|
20101025 Health Services |
- |
13 Jan 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
20101025 Health Services |
- |
09 Jan 2025
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Announces First Commercial Sales of ARC-EX System
|
20101025 Health Services |
- |
19 Dec 2024
17:58 CET |
ONWARD MEDICAL |
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury
|
20101025 Health Services |
- |
19 Dec 2024
17:58 CET |
ONWARD MEDICAL |
ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chroniqu...
|
20101025 Health Services |
- |
12 Dec 2024
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability
|
20101025 Health Services |
- |
26 Nov 2024
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights
|
20101025 Health Services |
- |
19 Nov 2024
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke
|
20101025 Health Services |
- |
12 Nov 2024
07:30 CET |
ONWARD MEDICAL |
ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
|
20101025 Health Services |
- |
31 Oct 2024
06:30 CET |
ONWARD MEDICAL |
ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024
|
20101025 Health Services |
- |
28 Oct 2024
17:45 CET |
ONWARD MEDICAL |
ONWARD® Medical Publishes Closing of Bookbuild Offering
|
20101025 Health Services |
- |
24 Oct 2024
17:45 CEST |
ONWARD MEDICAL |
ONWARD® Medical Publishes Prospectus for Listing of New Shares
|
20101025 Health Services |
- |
24 Oct 2024
07:30 CEST |
ONWARD MEDICAL |
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
|
20101025 Health Services |
- |
24 Oct 2024
07:30 CEST |
ONWARD MEDICAL |
ONWARD® Medical lève avec succès 50 millions d’euros dans le cadre d’une levée de fonds majorée avec le soutien d’Ottobock SE & Co. KGaA
|
20101025 Health Services |
- |
22 Oct 2024
20:21 CEST |
ONWARD MEDICAL |
ONWARD® Medical lance une augmentation de capital d’un montant d’environ 40 millions d’euros dont 22,5 millions d’engagement ferme de la part d’Ottobock SE & Co. KGaA
|
20101025 Health Services |
- |
22 Oct 2024
17:45 CEST |
ONWARD MEDICAL |
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA
|
20101025 Health Services |
- |
21 Oct 2024
07:30 CEST |
ONWARD MEDICAL |
ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman
|
20101025 Health Services |
- |
15 Oct 2024
07:30 CEST |
ONWARD MEDICAL |
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
|
20101025 Health Services |
- |
15 Oct 2024
07:30 CEST |
ONWARD MEDICAL |
ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec
|
20101025 Health Services |
- |
20 Sep 2024
19:45 CEST |
ONWARD MEDICAL |
ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
|
20101025 Health Services |
- |